KEGG   DRUG: フェノフィブラート
エントリ  
D00565                      Drug                                   
一般名   
フェノフィブラート (JP18);
Fenofibrate (JP18/USP/INN)
商品名   
  後発品
米国の商品 
  後発品
FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (A-S Medication Solutions), FENOFIBRATE (ANI Pharmaceuticals), FENOFIBRATE (ANI Pharmaceuticals), FENOFIBRATE (Ajanta Pharma USA), FENOFIBRATE (Ajanta Pharma USA), FENOFIBRATE (Alembic Pharmaceuticals Limited), FENOFIBRATE (Alembic Pharmaceuticals Limited), FENOFIBRATE (Alembic Pharmaceuticals Limited), FENOFIBRATE (Alembic Pharmaceuticals Limited), FENOFIBRATE (Alembic Pharmaceuticals), FENOFIBRATE (Alembic Pharmaceuticals), FENOFIBRATE (Alembic Pharmaceuticals), FENOFIBRATE (Alembic Pharmaceuticals), FENOFIBRATE (Alembic Pharmaceuticals), FENOFIBRATE (American Health Packaging), FENOFIBRATE (American Health Packaging), FENOFIBRATE (American Health Packaging), FENOFIBRATE (Amneal Pharmaceuticals NY LLC), FENOFIBRATE (Amneal Pharmaceuticals NY LLC), FENOFIBRATE (Amneal Pharmaceuticals NY LLC), FENOFIBRATE (Amneal Pharmaceuticals of New York LLC), FENOFIBRATE (Aphena Pharma Solutions - Tennessee), FENOFIBRATE (Aphena Pharma Solutions - Tennessee), FENOFIBRATE (Aphena Pharma Solutions - Tennessee), FENOFIBRATE (Apotex Corp.), FENOFIBRATE (Aurobindo Pharma Limited), FENOFIBRATE (Aurobindo Pharma Limited), FENOFIBRATE (Aurobindo Pharma Limited), FENOFIBRATE (Austarpharma), FENOFIBRATE (AvKARE), FENOFIBRATE (AvKARE), FENOFIBRATE (AvPAK), FENOFIBRATE (AvPAK), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Bryant Ranch Prepack), FENOFIBRATE (Camber Pharmaceuticals), FENOFIBRATE (Cipla USA Inc.,), FENOFIBRATE (Cipla USA), FENOFIBRATE (Creekwood Pharmaceuticals LLC), FENOFIBRATE (Dr. Reddy's Laboratories Limited), FENOFIBRATE (Dr. Reddy's Laboratories), FENOFIBRATE (Glenmark Pharmaceuticals), FENOFIBRATE (Golden State Medical Supply), FENOFIBRATE (Golden State Medical Supply), FENOFIBRATE (Golden State Medical Supply), FENOFIBRATE (Graviti Pharmaceuticals Private Limited), FENOFIBRATE (Graviti Pharmaceuticals Private Limited), FENOFIBRATE (Laurus Labs Limited), FENOFIBRATE (Laurus Labs Limited), FENOFIBRATE (Leading Pharma), FENOFIBRATE (Leading Pharma), FENOFIBRATE (Lifestar Pharma LLC), FENOFIBRATE (Lupin Pharmaceuticals), FENOFIBRATE (Lupin Pharmaceuticals), FENOFIBRATE (Lupin Pharmaceuticals), FENOFIBRATE (Major Pharmaceuticals), FENOFIBRATE (Major Pharmaceuticals), FENOFIBRATE (Mylan Institutional), FENOFIBRATE (Mylan Pharmaceuticals), FENOFIBRATE (Mylan Pharmaceuticals), FENOFIBRATE (Mylan Pharmaceuticals), FENOFIBRATE (NCS HealthCare of KY), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (Northwind Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (NuCare Pharmaceuticals), FENOFIBRATE (PD-Rx Pharmaceuticals), FENOFIBRATE (Preferred Pharmaceuticals), FENOFIBRATE (Preferred Pharmaceuticals), FENOFIBRATE (Preferred Pharmaceuticals), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (Proficient Rx LP), FENOFIBRATE (QUALLENT PHARMACEUTICALS HEALTH LLC), FENOFIBRATE (Quality Care Products), FENOFIBRATE (REMEDYREPACK), FENOFIBRATE (REMEDYREPACK), FENOFIBRATE (REMEDYREPACK), FENOFIBRATE (Rhodes Pharmaceuticals L.P.), FENOFIBRATE (Rhodes Pharmaceuticals L.P.), FENOFIBRATE (Solco Healthcare US), FENOFIBRATE (St. Mary's Medical Park Pharmacy), FENOFIBRATE (Sun Pharmaceutical Industries), FENOFIBRATE (Sun Pharmaceutical Industries), FENOFIBRATE (Sun Pharmaceutical Industries), FENOFIBRATE (Torrent Pharmaceuticals Limited), FENOFIBRATE (Westminster Pharmaceuticals)
組成式   
C20H21ClO4
質量    
360.1128
分子量   
360.8313
構造式   
Simcomp   
クラス   
脂質降下薬
 DG01946  脂質低下薬
  DG01733  PPARα作動薬
   DG01547  フィブラート系脂質異常症治療薬
代謝酵素基質薬
 DG02924  UGT基質薬
コード   
同一コード: C07586
薬効分類: 2183
ATCコード: C10AB05
化学構造グループ: DG01548
商品 (DG01548): D00565<JP/US> D08890<US>
効能    
脂質異常症治療薬, トリグリセリド合成阻害薬, ペルオキシソーム増殖因子活性化受容体(PPARI)α作動薬
  疾患
高脂血症 [DS:H01635]
家族性高脂血症 [DS:H00155]
コメント  
クロフィブラート誘導体
ターゲット 
NR1C1 (PPARA) [HSA:5465] [KO:K07294]
  パスウェイ
hsa03320  PPAR シグナル伝達経路
hsa04920  アディポサイトカインシグナル伝達経路
代謝    
Enzyme: UGT [KO:K00699]
相互作用  

構造マップ 
map07222  ペルオキシソーム増殖剤活性化受容体 (PPAR) 作動薬
階層分類  
医療用医薬品の薬効分類 [BR:jp08301]
 2  個々の器官系用医薬品
  21  循環器官用薬
   218  高脂血症用剤
    2183  クロフィブラート系製剤
     D00565  フェノフィブラート (JP18)
医療用医薬品のATC分類 [BR:jp08303]
 C 循環器系
  C10 脂質修飾剤
   C10A 脂質修飾剤、単剤
    C10AB フィブラート
     C10AB05 フェノフィブラート
      D00565  フェノフィブラート (JP18) <JP/US>
医療用医薬品のUSP分類 [BR:jp08302]
 心血管治療薬
  脂質異常症治療薬, フィブリン酸誘導体
   フェノフィブラート
    D00565  フェノフィブラート (JP18)
医薬品グループ [BR:jp08330]
 脂質降下薬
  DG01946  脂質低下薬
   DG01733  PPARα作動薬
    DG01547  フィブラート系脂質異常症治療薬
     DG01548  フェノフィブラート
      D00565  フェノフィブラート
 代謝酵素基質薬
  DG02924  UGT基質薬
   DG01548  フェノフィブラート
    D00565  フェノフィブラート
医薬品クラス [BR:jp08332]
 心血管系用薬
  DG01946  脂質低下薬 [商品一覧]
   D00565  フェノフィブラート
ターゲットに基づく医薬品分類 [BR:jp08310]
 核内受容体
  甲状腺ホルモン様受容体
   ペルオキシソーム増殖因子活性化受容体 (PPAR)
    NR1C1 (PPARA)
     D00565  フェノフィブラート (JP18) <JP/US>
日本薬局方収載医薬品 [BR:jp08311]
 化学薬品等
  D00565  フェノフィブラート
  D00565  フェノフィブラート錠
薬物代謝酵素とトランスポーター [jp08309.html]
 薬物代謝酵素
  D00565
医薬品グループ [BR:jp08330]
 脂質降下薬
  DG01946  脂質低下薬
   DG01733  PPARα作動薬
    DG01547  フィブラート系脂質異常症治療薬
     DG01548  フェノフィブラート
 代謝酵素基質薬
  DG02924  UGT基質薬
   DG01548  フェノフィブラート
リンク   
CAS: 49562-28-9
PubChem: 7847631
PDB-CCD: J3O[PDBj]
LigandBox: D00565
日化辞: J10.021H
LinkDB    

» English version   » Back

DBGET integrated database retrieval system